Lenolidamide for the salem VAMC for patient care

Active Awarded Last action

Contract number
36C24626N0421
Awardee
Awarding agency
Obligated
$1,204,555

Award facts

Contract value 100% obligated
$1,204,555.32 Current and potential, with all options
Completion date 76% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Boca Raton, FL 33432, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a delivery order valued at $1.2 million to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide to support patient care at the Salem VA Medical Center. This firm fixed-price delivery order, issued on January 15, 2026, with an ultimate completion date of January 14, 2027, falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and was not issued under any set-aside designation. Exelan Pharmaceuticals, headquartered in Boca Raton, Florida, will perform the work at its primary facility, providing pharmaceutical products for oncology and hematologic malignancy treatment protocols across the VA healthcare system.

Exelan Pharmaceuticals is an established federal pharmaceutical supplier with an extensive portfolio of Indefinite Delivery Contracts and Blanket Purchase Agreements serving the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The company specializes in the production, distribution, and repackaging of generic and branded pharmaceutical products into patient-ready prescriptions and distribution packages. This delivery order represents a component of Exelan's broader relationship with the VA National Acquisition Center and Veterans Integrated Service Networks, through which the company supplies critical medications including Lenalidomide across multiple strengths and formulations. The company operates as a prime contractor performing substantially all work in-house with no identified major subcontractors.

Quick answers

Who was awarded contract 36C24626N0421?

36C24626N0421 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on January 15, 2026.

How much is contract 36C24626N0421 worth?

The government has obligated $1,204,555 on 36C24626N0421.

Is contract 36C24626N0421 an order under another contract?

Yes. 36C24626N0421 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24626N0421 competed?

The extent of competition for 36C24626N0421 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award